124 related articles for article (PubMed ID: 20823409)
1. Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate.
Giard C; Avenel-Audran M; Croué A; Verret JL; Martin L
J Clin Oncol; 2010 Dec; 28(34):e717-8. PubMed ID: 20823409
[No Abstract] [Full Text] [Related]
2. Methotrexate-induced and Epstein-Barr virus-associated B-cell lymphoma of the spine: MR and PET/CT imaging.
Nguyen BD; Roarke MC; McCullough AE
Clin Nucl Med; 2008 Mar; 33(3):208-10. PubMed ID: 18287849
[No Abstract] [Full Text] [Related]
3. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.
Tournadre A; D'Incan M; Dubost JJ; Franck F; Déchelotte P; Souteyrand P; Soubrier M
Mayo Clin Proc; 2001 Aug; 76(8):845-8. PubMed ID: 11499826
[TBL] [Abstract][Full Text] [Related]
5. Maxillary angiocentric EBV-associated large B cell lymphoma associated with methotrexate treatment.
Nava VE; Sartorelli JS; Ozdemirli M
J Oral Maxillofac Surg; 2008 Jul; 66(7):1557-8. PubMed ID: 18571052
[No Abstract] [Full Text] [Related]
6. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
Gibson SE; Hsi ED
Hum Pathol; 2009 May; 40(5):653-61. PubMed ID: 19144386
[TBL] [Abstract][Full Text] [Related]
7. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
8. [Regression of Epstein-Barr virus associated lymphoma after methotrexate and cyclosporine A withdrawal in a patient with rheumathoid arthritis].
Doña Naranjo MA; Vargas Lebrón C; Riesco Díaz M
Med Clin (Barc); 2001 Nov; 117(14):556-7. PubMed ID: 11707225
[No Abstract] [Full Text] [Related]
9. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.
Fam AG; Perez-Ordonez B; Imrie K
J Rheumatol; 2000 Jun; 27(6):1546-9. PubMed ID: 10852288
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
[TBL] [Abstract][Full Text] [Related]
11. Evidence for polyclonal infection of Epstein-Barr virus in a patient with primary cutaneous anaplastic large cell lymphoma.
Shimauchi T; Onoue A; Yamamoto O; Hino R; Tokura Y
Clin Exp Dermatol; 2004 Jul; 29(4):383-6. PubMed ID: 15245536
[TBL] [Abstract][Full Text] [Related]
12. Granuloma annulare heralding angioimmunoblastic T-cell lymphoma in a patient with a history of epstein-barr virus-associated B-cell lymphoma.
Martin JE; Wagner AJ; Murphy GF; Pinkus GS; Wang LC
J Clin Oncol; 2009 Nov; 27(31):e168-71. PubMed ID: 19770367
[No Abstract] [Full Text] [Related]
13. Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma.
Kikuchi A; Anzai H; Kosuge H; Naka W; Nishikawa T
Br J Dermatol; 1997 Jan; 136(1):124-8. PubMed ID: 9039311
[TBL] [Abstract][Full Text] [Related]
14. Reversible cutaneous lymphoma occurring during methotrexate therapy.
Viraben R; Brousse P; Lamant L
Br J Dermatol; 1996 Jul; 135(1):116-8. PubMed ID: 8776373
[TBL] [Abstract][Full Text] [Related]
15. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
[TBL] [Abstract][Full Text] [Related]
16. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient.
Chiu LS; Choi PC; Luk NM; Chang M; Tang WY
Clin Exp Dermatol; 2009 Jul; 34(5):e21-4. PubMed ID: 19508468
[TBL] [Abstract][Full Text] [Related]
18. A case of primary Epstein-Barr virus-associated cutaneous diffuse large B-cell lymphoma unassociated with iatrogenic or endogenous immune dysregulation.
Tokuda Y; Fukushima M; Nakazawa K; Oguchi S; Koganehira Y; Yamaura M; Iijima M; Murata H; Uhara H; Takata M; Saida T; Katsuyama T; Nakamura S
J Cutan Pathol; 2008 Jul; 35(7):666-71. PubMed ID: 18201237
[TBL] [Abstract][Full Text] [Related]
19. An Epstein-Barr virus-associated pulmonary lymphoproliferative disorder as complication of immunosuppression.
Van Haarlem SW; Verpalen MC; Van Gorp JM; Hoekstra JB; Van Den Bosch JM
Neth J Med; 2000 Oct; 57(4):165-8. PubMed ID: 11006493
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-related nasal and cutaneous T-cell lymphoma in an immunosuppressed patient.
Sivaji N; Wardrop P; Vosylius P; Jarrett R
Br J Haematol; 2004 May; 125(3):266. PubMed ID: 15086408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
